The legislation will advance groundbreaking medical innovation and research that will help millions of Americans with life-threatening diseases.
Congress has four remaining work weeks in Washington to hash out the budget and hopefully finish work on the “21st Century Cures” legislation.
As the Chicago Cubs celebrate their historic victory, policymakers will deliberate over legislation to set the stage for the next century of medical discoveries.
Emerging therapies offer the promise of cures for those with Alzheimer’s, cancer, Parkinson’s, and other life-threatening diseases.
There are only 500 approved treatments for the approximately 10,000 known molecular-based diseases. The urgency of finding the next generation of cures is clear.
Few cell therapies are accessible to patients given current regulations, which require up to $1 billion and years of development time before a therapy can get to market.
At its all-time high in 1964, federal R&D spending amounted to almost 2 percent of GDP. Today, it’s just 0.7 percent—the lowest level in over 50 years.
BPC announced that it will explore new policies to expand the use of health care data, which could reduce the time and cost of bringing safe and effective drugs to the market.